









Markets
/
Stocks
/
nasdaq-wat
/

Waters Corp

WAT

299.040USD

+3.650+1.24%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

17.80BMarket Cap

26.91P/E TTM



Waters Corp

299.040

+3.650+1.24%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-15

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

16 / 207

Overall Ranking

100 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 18 analysts

Buy

Current Rating

355.804

Target Price

+20.45%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments.

Fairly Valued

The company’s latest PE is 26.86, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 57.76M shares, increasing 0.34% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 7.38M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-15

The company's current financial score is 7.79, which is higher than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 661.71M, representing a year-over-year increase of 3.90%, while its net profit experienced a year-over-year increase of 18.77%.

Score

Industry at a Glance

Previous score

7.79

Change

0.05



Financials

9.76

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.50

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.13

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.53

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.30

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-15

The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 26.46, which is 19.86% below the recent high of 31.72 and 0.87% above the recent low of 26.24.

Score

Industry at a Glance

Previous score

5.98

Change

-0.01

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 16/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-15

The company’s current earnings forecast score is 7.26, which is lower than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Waters Corp is 344.00, with a high of 460.00 and a low of 315.00.

Score

Industry at a Glance

Previous score

7.22

Change

Support & Resistance

No Data

Analyst Rating

Based on 18 analysts

Buy

Current Rating

355.804

Target Price

+20.45%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Waters Corp

WAT

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-15

The company’s current price momentum score is 8.88, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 307.70 and the support level at 278.31, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.67

Change

0.21

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(5)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

1.050

Neutral

RSI(14)

50.301

Neutral

STOCH(KDJ)(9,3,3)

49.964

Neutral

ATR(14)

8.948

High Vlolatility

CCI(14)

-9.128

Neutral

Williams %R

47.689

Neutral

TRIX(12,20)

0.085

Sell

StochRSI(14)

66.083

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

298.086

Buy

MA10

299.235

Sell

MA20

297.900

Buy

MA50

299.519

Sell

MA100

324.062

Sell

MA200

350.262

Sell

Institutional Confidence

Currency: USD Updated：2025-09-15

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 97.04%, representing a quarter-over-quarter decrease of 1.70%. The largest institutional shareholder is The Vanguard, holding a total of 7.38M shares, representing 12.40% of shares outstanding, with 4.14% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

7.25M

+2.46%

AllianceBernstein L.P.

3.07M

+15.70%

BlackRock Institutional Trust Company, N.A.

3.85M

+2.01%

Fundsmith LLP

3.61M

-0.59%

State Street Global Advisors (US)

2.64M

+1.40%

MFS Investment Management

1.97M

+7.15%

Geode Capital Management, L.L.C.

1.51M

+4.05%

Fundsmith Investment Services Ltd.

1.22M

-0.74%

Walter Scott & Partners Ltd.

1.15M

-4.05%

Janus Henderson Investors

901.48K

+1.37%

Risk Assessment

Currency: USD Updated：2025-09-15

The company's beta value is 1.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.